WINBP CT 40/6.25MG TABLET is a combination of Chlorthalidone and Olmesartan which belongs to the group of medicines called Thiazide diuretics and Angiotensin-II receptor antagonists respectively. WINBP CT 40/6.25MG TABLET is indicated for the management of essential hypertension.
Essential hypertension (also known as primary hypertension) is a medical condition in which the force of the blood exerted against the walls of the artery remains very high and as a result, it may lead to severe damage to the walls of blood vessels supplying various important organs. It occurs without any known secondary cause and if it remains unmanageed it can lead to severe problems such as heart attack, heart or kidney failure, stroke or even blindness.
Along management with WINBP CT 40/6.25MG TABLET follow lifestyle modifications (such as losing weight, quitting smoking or alcohol intake) as advised by your physician along with a healthy balanced diet and regular physical activity (such as walking or swimming).
During the course of the management with WINBP CT 40/6.25MG TABLET, your doctor might regularly check your blood pressure, kidney function and electrolyte balance to avoid the risk of side effects. Avoid eating grapefruit or consuming grapefruit juice while taking WINBP CT 40/6.25MG TABLET as it could potentiate the blood pressure-lowering effect of this medicine.
Before taking WINBP CT 40/6.25MG TABLET, inform your doctor if you have diabetes, liver, kidney or heart disease as a precaution. WINBP CT 40/6.25MG TABLET is strictly not recommended for use in pregnant or breastfeeding women as it could cause serious harm to the baby.
WINBP CT 40/6.25MG TABLET is not recommended for use in children and adolescents (aged below 18 years) due to a lack of safety data. It should be used with extreme caution in elderly patients (aged 65 years or above).
The most common side effects of taking WINBP CT 40/6.25MG TABLET are headache, dizziness, tiredness, nausea, stomach pain, lack of...
No content available
